31st Oct 2006 07:00
Tate & Lyle Board Appointment Tate & Lyle PLC announces today that Elisabeth ("Liz") Airey has been appointedas a Non-Executive Director with effect from 1 January 2007. Liz Airey (47) has over twenty years experience in banking, corporate advisoryand finance. She worked from 1990 to 1999 as Finance Director of Monument Oiland Gas plc until its sale to Lasmo plc. She currently has a portfolio of rolesincluding as a director at the oil industry specialist corporate financeboutique, Harrison Lovegrove & Co Limited, as a Non-Executive Director of AMECplc and as Chairman of both The JP Morgan European Fledgeling Investment TrustPLC and Zetex plc, the quoted semiconductor company. Sir David Lees, Chairman of Tate & Lyle, said "I am delighted that Liz Airey isto join the Board as a Non-Executive Director. Her extensive financial andbusiness management experience will be of great benefit to the Board." \* TCONTACTSFerne Hudson, Head of Media and Press RelationsTel: 020 7626 6525 or Mobile 07713 067433 Mark Robinson, Director of Investor RelationsTel: 020 7626 6525 or Mobile: 07793 515861 [email protected]\* T About Tate & Lyle: Tate & Lyle is a world leading manufacturer of renewable foodand industrial ingredients. It uses innovative technology to transform corn,wheat and sugar into value-added ingredients for customers in the food,beverage, pharmaceutical, cosmetic, paper, packaging and building industries.The Company is a leader in cereal sweeteners and starches, sugar refining, valueadded food and industrial ingredients, and citric acid. Tate & Lyle is the worldnumber-one in industrial starches and is the sole manufacturer of SPLENDA(R)Sucralose. Headquartered in London, Tate & Lyle is listed on the London Stock Exchangeunder the symbol TATE.L. In the US its ADRs trade under TATYY. The Companyoperates more than 65 production facilities in 29 countries, throughout Europe,the Americas and South East Asia. It employs 7,000 people in its subsidiarieswith a further 4,800 employed in joint ventures. Sales in the year to 31 March2006 totalled £3.7 billion. Additional information can be found on this websitewww.tateandlyle.com. SPLENDA(R) and the SPLENDA(R) logo are trademarks of McNeil Nutritionals, LLC Copyright Business Wire 2006Related Shares:
Tate & Lyle